Literature DB >> 27895435

Optimal MRI interval for detection of asymptomatic recurrence in surgically treated early cervical cancer by use of a mathematical model.

A Laios1, K Gubbala1, R Lampe2, A Tolis3.   

Abstract

INTRODUCTION: Applications of mathematical modeling may provide an insight into the timing of surveillance modalities. We aimed to determine the optimal magnetic resonance imaging (MRI) interval for the detection of surgically treated early cervical cancer asymptomatic recurrence by using a mathematical model for volumetric tumor growth time.
METHODS: We assumed that tumor volume increases by a factor equal to the basis of natural logarithms (e~2.718) at constant time intervals. Using a mathematical formula, the tumor volume (V) was converted to diameter (D), which could be expressed as a function of time (t), given an initial diameter Di (corresponding to initial volume Vi) and a constant DT, where DT is the time required for volumetric tumor growth by a factor (e). Three different DTs were used for demonstration of the model, i.e. 20, 100 and 400 days.
RESULTS: Assuming complete surgical clearance, a worst-case scenario for a 20-day DT indicated that a 20 μm cervical tumor would need at least 12 months to reach 10 mm in diameter, which would be detected with an annual surveillance interval MRI. Over a 5-year (60 months) follow-up, nearly five surveillance MRIs would be required if the threshold of 10 mm was desired. For a 100-day DT over a 5-year (60 months) follow-up, a single only MRI would be required, if the threshold of 10 mm was desired. In the case of an indolent tumor (DT is 400 days), the model would not recommend a surveillance MRI to detect asymptomatic recurrence. A positive linear association between optimal MRI intervals and volumetric tumor DTs was demonstrated.
CONCLUSION: In the absence of evidence, we postulate annual MRI scanning is probably the shortest interval, which can be clinically useful for optimization of routine surveillance follow-up protocols in surgically treated early cervical cancer. This mathematical model requires proper verification in prospective clinical studies. Hippokratia 2016, 20(1): 4-8.

Entities:  

Keywords:  Cervical cancer; mathematical model; optimal MRI interval; tumor growth

Year:  2016        PMID: 27895435      PMCID: PMC5074396     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  23 in total

1.  Surgical management and follow-up of patients with cervical cancer: survey of gynaecological oncologists in the UK.

Authors:  M A E Nobbenhuis; L Balasubramani; D F Kolomainen; D P J Barton
Journal:  J Obstet Gynaecol       Date:  2012-08       Impact factor: 1.246

Review 2.  Follow-up for women after treatment for cervical cancer: a systematic review.

Authors:  Laurie Elit; Anthony W Fyles; Michaela C Devries; Thomas K Oliver; Michael Fung-Kee-Fung
Journal:  Gynecol Oncol       Date:  2009-06-26       Impact factor: 5.482

Review 3.  Adenocarcinoma: a unique cervical cancer.

Authors:  Lilian T Gien; Marie-Claude Beauchemin; Gillian Thomas
Journal:  Gynecol Oncol       Date:  2009-10-31       Impact factor: 5.482

Review 4.  Cell production rates in human tissues and tumours and their significance. Part II: clinical data.

Authors:  D A Rew; G D Wilson
Journal:  Eur J Surg Oncol       Date:  2000-06       Impact factor: 4.424

5.  Breast cancer: computer simulation method for estimating optimal intervals for screening.

Authors:  J S Michaelson; E Halpern; D B Kopans
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

6.  Optimum overall times II: Extended modelling for head and neck radiotherapy.

Authors:  J F Fowler
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-12-26       Impact factor: 4.126

7.  Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.

Authors:  H M Shingleton; S J Soong; M S Gelder; K D Hatch; V V Baker; J M Austin
Journal:  Obstet Gynecol       Date:  1989-06       Impact factor: 7.661

Review 8.  Surveillance procedures for patients for cervical carcinoma: a review of the literature.

Authors:  Vanna Zanagnolo; Lucas Alfonso Minig; Angelo Gadducci; Tiziano Maggino; E Sartori; Paolo Zola; Fabio Landoni
Journal:  Int J Gynecol Cancer       Date:  2009-04       Impact factor: 3.437

9.  Tumor doubling time of cutaneous melanoma and its metastasis.

Authors:  J Andrew Carlson
Journal:  Am J Dermatopathol       Date:  2003-08       Impact factor: 1.533

Review 10.  Application of artificial intelligence to the management of urological cancer.

Authors:  Maysam F Abbod; James W F Catto; Derek A Linkens; Freddie C Hamdy
Journal:  J Urol       Date:  2007-08-14       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.